
Adding immunotherapy to standard chemotherapy significantly improves outcomes in advanced endometrial cancer.


coremsg

Two new studies show that adding immunotherapy with pembrolizumab or dostarlimab to chemotherapy significantly boosts progression-free survival in patients with advanced endometrial cancer.

'Home Run': Immunotherapy Add-on for Advanced Endometrial Cancer

immunotherapy-impact-on-endometrial-cancer-treatment


Immunotherapy Impact on Endometrial Cancer Treatment
